Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
The European Journal of Neuroscience|September 25, 2020
The neuropharmacology of cannabinoid receptor ligands in central signaling pathwaysTibor M Brunt, Matthijs G BossongClinical Toxicology (Philadelphia, Pa.)|January 26, 2016
How toxic is ibogaine?Ruud P W Litjens, Tibor M BruntDrug Testing and Analysis|September 8, 2011
The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparisonTibor M Brunt, Raymond J M NiesinkMolecular Psychiatry|August 23, 2025
Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effectsAdam J Drewko, Ron L P Habets, Tibor M BruntInternational Journal of Molecular Sciences|December 11, 2022
Mechanisms Involved in the Neurotoxicity and Abuse Liability of Nitrous Oxide: A Narrative ReviewTibor M Brunt, Wim van den Brink, Jan van AmsterdamAddiction (Abingdon, England)|December 23, 2024
Rare but relevant: Nitrous oxide and peripheral neurotoxicity, what do we know?Tibor M Brunt, Wim van den Brink, Jan van AmsterdamThe International Journal on Drug Policy|July 12, 2011
Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The NetherlandsTibor M Brunt, Raymond J M Niesink, Wim van den BrinkAddiction (Abingdon, England)|August 13, 2016
Is online information on ecstasy tablet content safe?Ruben Q Vrolijk, Tibor M Brunt, Annabel Vreeker, et al.Addiction (Abingdon, England)|August 4, 2015
Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15Raymond J M Niesink, Sander Rigter, Maarten W Koeter, et al.Current Pharmaceutical Design|September 5, 2013
GHB, GBL and 1,4-BD addictionTibor M Brunt, Jan G C van Amsterdam, Wim van den BrinkPageof 4